SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Biotech Showcase 2023
Event | 01. 11. 2023
Peter Young will be participating on a panel titled "Early Seed Financing: Funding Strategies to Prepare Start-Ups for Growth" on Wednesday, January 11th at the Biotech Showcase 2023 in San Francisco.
